ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AXNX Axonics Inc

66.69
0.15 (0.23%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Axonics Inc AXNX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.15 0.23% 66.69 19:00:00
Open Price Low Price High Price Close Price Previous Close
66.75 66.50 66.875 66.69 66.54
more quote information »

Recent News

Date Time Source Heading
4/24/202405:30PRNUSBoston Scientific Announces Results for First Quarter 2024
3/22/202415:01BWAxonics Stockholders Approve Merger Agreement with Boston..
3/21/202415:54BWAxonics Provides Update on Inter Partes Review Proceedings
3/14/202405:00BWAxonics Receives CE Mark Approval for Fourth-Generation..
3/07/202416:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2/29/202415:01BWAxonics Responds to ITC Action by Medtronic
2/28/202415:05EDGAR2Form 8-K - Current report
2/28/202415:01BWAxonics Reports Fourth Quarter and Fiscal Year 2023..
2/22/202407:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
2/02/202417:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/31/202405:30PRNUSBoston Scientific Announces Results for Fourth Quarter and..
1/10/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/10/202414:07PRNUSKuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to..
1/08/202416:19EDGAR2Form DEF 14A - Other definitive proxy statements
1/08/202416:19EDGAR2Form 8-K - Current report
1/08/202415:55PRNUSALERT: Rowley Law PLLC is Investigating Proposed Acquisition..
1/08/202410:36DJNAxonics Shares Climb 20% After Acquisition by Boston..
1/08/202407:47EDGAR2Form 8-K - Current report
1/08/202406:41DJNBoston Scientific To Acquire Axonics For About $3.7 Billion
1/08/202406:00BWAxonics Announces Definitive Agreement to be Acquired by..
12/28/202318:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202315:01BWAxonics to Present at the J.P. Morgan Healthcare Conference
12/26/202312:31EDGAR2Form 144 - Report of proposed sale of securities
11/06/202311:00GLOBERevolutionizing Care: NeuroQure’s Groundbreaking Path to..
11/01/202305:00BWAxonics to Participate in November Investor Conferences
10/30/202315:06EDGAR2Form 8-K - Current report
10/30/202315:01BWAxonics Reports Third Quarter 2023 Financial Results
10/06/202319:04EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/04/202315:08EDGAR2Form 8-K - Current report
10/03/202318:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202305:00BWAxonics to Report Third Quarter 2023 Financial Results on..
8/25/202305:00BWAxonics to Participate in September Investor Conferences
8/21/202316:59EDGAR2Form 144 - Report of proposed sale of securities
8/21/202316:30EDGAR2Form 8-K - Current report
8/21/202305:00BWAxonics Announces CFO Retirement and Appoints Successor
7/31/202316:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/27/202315:05EDGAR2Form 8-K - Current report
7/27/202315:01BWAxonics Reports Second Quarter 2023 Financial Results
6/29/202305:00BWAxonics to Report Second Quarter 2023 Financial Results on..
6/28/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202319:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
5/01/202315:01BWAxonics Reports First Quarter 2023 Financial Results

Your Recent History

Delayed Upgrade Clock